Thursday, June 19, 2025
Ghana News Online
Advertisement
  • News
    The Value of Friendship in Life

    Ban sugary snacks, carbonated drinks in Ghana schools – Pastor Alao-Caesar

    Mahama appoints Dr Randy Abbey as acting COCOBOD CEO

    NDC primaries: No tie in Ketu North, Edem Agbana declared the winner

    NDC primaries: No tie in Ketu North, Edem Agbana declared the winner

    Don’t Politicize the Civil Service

    Don’t Politicize the Civil Service

    The Magic of improved sex life

    The Magic of improved sex life

    So It’s a New Year – Pastor Alao-Caesar

    So It’s a New Year – Pastor Alao-Caesar

    Trending Tags

    • Commentary
    • Featured
    • Event
    • Editorial
  • Politics
  • National
  • Business
  • World
  • Opinion
  • Tech
  • Science
  • Lifestyle
  • Entertainment
  • Health
  • Travel
  • News
    The Value of Friendship in Life

    Ban sugary snacks, carbonated drinks in Ghana schools – Pastor Alao-Caesar

    Mahama appoints Dr Randy Abbey as acting COCOBOD CEO

    NDC primaries: No tie in Ketu North, Edem Agbana declared the winner

    NDC primaries: No tie in Ketu North, Edem Agbana declared the winner

    Don’t Politicize the Civil Service

    Don’t Politicize the Civil Service

    The Magic of improved sex life

    The Magic of improved sex life

    So It’s a New Year – Pastor Alao-Caesar

    So It’s a New Year – Pastor Alao-Caesar

    Trending Tags

    • Commentary
    • Featured
    • Event
    • Editorial
  • Politics
  • National
  • Business
  • World
  • Opinion
  • Tech
  • Science
  • Lifestyle
  • Entertainment
  • Health
  • Travel
No Result
View All Result
Morning News
No Result
View All Result
Home CORONAVIRUS

Oxford University COVID-19 vaccine ‘induces positive immune response’, first phase of human trials shows

by GH News Online
July 20, 2020
in CORONAVIRUS, Featured
0
Oxford University COVID-19 vaccine ‘induces positive immune response’, first phase of human trials shows
0
SHARES
150
VIEWS
Share on FacebookShare on Twitter

A coronavirus vaccine being developed at the University of Oxford is safe and induces an immune response to the disease, the first phase of human trials has revealed.

Doses of the vaccine, called AZD1222, were given to 1,077 healthy adults aged between 18 and 55 in five UK hospitals in April and May as part of the phase one clinical trial for the vaccine being developed by AstraZeneca and scientists at the University of Oxford.

The results – published in The Lancet journal on Monday – show they induced strong antibody and T-cell immune responses for up to 56 days after they were given.

READ ALSO

The Value of Friendship in Life

The Electricity Company of Ghana Must Fix Its Online Prepaid Purchase Problems

T-cells are crucial for maintaining protection against the virus for years.

Scientists found the response could be even greater after a second dose of the vaccine.Compared to a control group, who were given a meningitis vaccine, the COVID-19 vaccine caused minor side effects more frequently, but those could be reduced by taking paracetamol. There were no serious adverse effects from the vaccine, the report said.

The UK government has made a deal with AstraZeneca and the University of Oxford to secure access to 100 million doses of the vaccine.

Professor Andrew Pollard, who is leading the study at the University of Oxford, said: “The immune system has two ways of finding and attacking pathogens – antibody and T cell responses.

“This vaccine is intended to induce both, so it can attack the virus when it’s circulating in the body, as well as attacking infected cells.

“We hope this means the immune system will remember the virus so that our vaccine will protect people for an extended period.

“However, we need more research before we can confirm the vaccine effectively protects against SARS-CoV-2 infection, and for how long any protection lasts.”

Although these results are from phase one of the trials, phase two testing is already underway in the UK and phase three testing on volunteers in Brazil and South Africa is also taking place.

AstraZeneca’s vaccine is among the leading candidates among several others around the world, including an injection being developed by China’s Sinovac Biotech, another from state-owned Chinese firm Sinopharm and one from US biotech firm Moderna.

The UK government has also secured early access to 90m COVID-19 vaccine doses through partnerships with pharmaceutical companies, including 30m of one being developed by BioNTech and Pfizer, and 60m from Valneva which has a factory in Scotland.

Source: Sky News

Tags: CoronavirusCOVID-19Oxford UniversityOxford University COVID-19 vaccine

Related Posts

The Value of Friendship in Life
Featured

The Value of Friendship in Life

December 1, 2024
The Electricity Company of Ghana Must Fix Its Online Prepaid Purchase Problems
Business

The Electricity Company of Ghana Must Fix Its Online Prepaid Purchase Problems

July 24, 2023
Andre Ayew’s Potential Return to Qatari or Saudi Arabian Football After Nottingham Forest Spell
Featured

Andre Ayew’s Potential Return to Qatari or Saudi Arabian Football After Nottingham Forest Spell

July 13, 2023
Unwavering Love: A Tribute to Fathers
Featured

Unwavering Love: A Tribute to Fathers

June 15, 2023
Ghana’s rising star, Kelvin Awuah Abanga, shines for Leganés Sub 19 Soccer Team.
Featured

Ghana’s rising star, Kelvin Awuah Abanga, shines for Leganés Sub 19 Soccer Team.

June 8, 2023
Unfortunate Decision by Ghana’s Supreme Court: Stifling Progress towards Regulated Cannabis Legalisation in Ghana
Business

Unfortunate Decision by Ghana’s Supreme Court: Stifling Progress towards Regulated Cannabis Legalisation in Ghana

May 28, 2023
Next Post
2020 Ballon d’Or cancelled due to coronavirus pandemic

2020 Ballon d’Or cancelled due to coronavirus pandemic

© 2020 GHNewsOnline.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • Politics
  • National
  • Business
  • World
  • Entertainment
  • Fashion
  • Food
  • Health
  • Lifestyle
  • Opinion
  • Science
  • Tech
  • Travel

© 2020 GHNewsOnline.